Kamau; Muthoni G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kamau; Muthoni G..The latest application filed is for "cyclic dinucleotides as anticancer agents".
- Kamau; Muthoni G. - Lawrenceville NJ
| Patent | Date |
|---|---|
| Cyclic dinucleotides as anticancer agents Grant 11,339,185 - Fink , et al. May 24, 2 | 2022-05-24 |
| Cyclic Dinucleotides As Anticancer Agents App 20220117995 - FINK; Brian E. ; et al. | 2022-04-21 |
| Cyclic Dinucleotides As Anticancer Agents App 20200270298 - HARIKRISHNAN; Lalgudi S. ; et al. | 2020-08-27 |
| Cyclic dinucleotides as anticancer agents Grant 10,744,150 - Fink , et al. A | 2020-08-18 |
| Cyclic Dinucleotides As Anticancer Agents App 20200079815 - FINK; Brian E. ; et al. | 2020-03-12 |
| Cyclic dinucleotides as anticancer agents Grant 10,519,187 - Fink , et al. Dec | 2019-12-31 |
| Cyclic Dinucleotides As Anticancer Agents App 20190248828 - Fink; Brian E. ; et al. | 2019-08-15 |
| Carbazole compounds useful as bromodomain inhibitors Grant 10,196,387 - Poss , et al. Fe | 2019-02-05 |
| Cyclic Dinucleotides As Anticancer Agents App 20190030057 - FINK; Brian E. ; et al. | 2019-01-31 |
| Carbazole compounds useful as bromodomain inhibitors Grant 10,053,454 - Poss , et al. August 21, 2 | 2018-08-21 |
| TGF.beta.R antagonists Grant 9,708,316 - Fink , et al. July 18, 2 | 2017-07-18 |
| Carbazole Compounds Useful As Bromodomain Inhibitors App 20170152248 - Poss; Michael A. ; et al. | 2017-06-01 |
| Tgf Beta R Antagonists App 20160176871 - Fink; Brian E. ; et al. | 2016-06-23 |
| Carbazole Compounds Useful As Bromodomain Inhibitors App 20160009701 - Poss; Michael A. ; et al. | 2016-01-14 |
| Heterocyclic CETP inhibitors Grant 8,642,576 - Salvati , et al. February 4, 2 | 2014-02-04 |
| Pyrrolotriazine kinase inhibitors Grant 8,445,676 - Purandare , et al. May 21, 2 | 2013-05-21 |
| Heterocyclic Cetp Inhibitors App 20120322761 - Salvati; Mark E. ; et al. | 2012-12-20 |
| Heterocyclic CETP inhibitors Grant 8,304,403 - Salvati , et al. November 6, 2 | 2012-11-06 |
| Pyrrolotriazine Kinase Inhibitors App 20110294816 - Purandare; Ashok Vinayak ; et al. | 2011-12-01 |
| Heterocyclic CETP inhibitors Grant 7,888,376 - Salvati , et al. February 15, 2 | 2011-02-15 |
| Heterocyclic Cetp Inhibitors App 20100267669 - Salvati; Mark E. ; et al. | 2010-10-21 |
| Heterocyclic CETP inhibitors Grant 7,790,770 - Salvati , et al. September 7, 2 | 2010-09-07 |
| Heterocyclic Cetp Inhibitors App 20070161685 - Salvati; Mark E. ; et al. | 2007-07-12 |
| Heterocyclic Cetp Inhibitors App 20070135631 - Salvati; Mark E. ; et al. | 2007-06-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 